BackVascular Biogenics Overview

Vascular Biogenics Receivables

Vascular Biogenics's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

Vascular Biogenics Receivables History

Loading

Vascular Biogenics vs. peers: Receivables Comparison

Loading

Vascular Biogenics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vascular Biogenics (VBLT) FAQ

As of the most recent data (June 2024), VBLT shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VBLT's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Vascular Biogenics is outperforming or lagging.

Tracking VBLT's receivables over time shows whether Vascular Biogenics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Vascular Biogenics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

Vascular Biogenics's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.